Paper · 37593607
Brevilin A exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling invitro.
Meng M and 5 others. Heliyon, 2023. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Brevilin A exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling invitro. Papers, record 37593607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37593607
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Brevilin A exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling invitro.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29,289,836 | Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29289836 | PubMed |
| 2 | 35,281,907 | Sesquiterpene Lactones Attenuate Paclitaxel Resistance Via Inhibiting MALAT1/STAT3/ FUT4 Axis and P-Glycoprotein Transporters in Lung Cancer Cells. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35281907 | PubMed |
| 3 | 31,282,895 | HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis. | J Vis Exp | 2019 | https://conductscience.org/library/papers/31282895 | PubMed |
| 4 | 31,500,389 | Brevilin A, a Sesquiterpene Lactone, Inhibits the Replication of Influenza A Virus In Vitro and In Vivo. | Viruses | 2019 | https://conductscience.org/library/papers/31500389 | PubMed |
| 5 | 32,328,177 | Brevilin A induces ROS-dependent apoptosis and suppresses STAT3 activation by direct binding in human lung cancer cells. | J Cancer | 2020 | https://conductscience.org/library/papers/32328177 | PubMed |
| 6 | 31,690,961 | Tumor angiogenesis: causes, consequences, challenges and opportunities. | Cell Mol Life Sci | 2020 | https://conductscience.org/library/papers/31690961 | PubMed |
| 7 | 34,170,703 | Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation. | J Med Chem | 2021 | https://conductscience.org/library/papers/34170703 | PubMed |
| 8 | 32,606,754 | Brevilin A, a Natural Sesquiterpene Lactone Inhibited the Growth of Triple-Negative Breast Cancer Cells via Akt/mTOR and STAT3 Signaling Pathways. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32606754 | PubMed |
| 9 | 27,832,950 | The chick embryo chorioallantoic membrane (CAM) assay. | Reprod Toxicol | 2017 | https://conductscience.org/library/papers/27832950 | PubMed |
| 10 | 31,371,781 | Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways. | Acta Pharmacol Sin | 2020 | https://conductscience.org/library/papers/31371781 | PubMed |
1 to 10 of 52
See all 52 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,835,949 | Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway. | Arthritis Res Ther | 2025 | https://conductscience.org/library/papers/40835949 | PubMed |
| 40,001,571 | Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer. | Biomolecules | 2025 | https://conductscience.org/library/papers/40001571 | PubMed |
| 39,350,981 | Matching traditional Chinese medicine and western medicine-based research: Advanced nutraceutical development for proactive gastric cancer prevention. | World J Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/39350981 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| BCL2L1 | 598 | PubTator's text mining | https://conductscience.org/library/genes/598 | NCBI Gene |
| DNTT | 1,791 | PubTator's text mining | https://conductscience.org/library/genes/1791 | NCBI Gene |
| EGFR | 1,956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| EP300 | 2,033 | PubTator's text mining | https://conductscience.org/library/genes/2033 | NCBI Gene |
| GAPDH | 2,597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| JAK2 | 3,717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
| MMP2 | 4,313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| NFKB1 | 4,790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| PCNA | 5,111 | PubTator's text mining | https://conductscience.org/library/genes/5111 | NCBI Gene |
1 to 10 of 22
See all 22 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37593607
GET https://conductscience.org/api/papers/v1/37593607/references?page=2